Taxus Express Atom Stent offers an alternative treatment choice for patients with small vessels who will now have the additional option of the Taxus Liberte Atom Stent.
Mark Turco, Director of the Center for Cardiac and Vascular Research at Washington Adventist Hospital, said: “The rapid adoption of the Taxus Express Atom Stent has confirmed the need for this type of stenting option in the treatment of small-vessel coronary artery disease,”
“The Taxus Liberté Atom Stent provides clear design and deliverability advantages. Additionally, in the Taxus Atlas Small Vessel clinical trial, the Taxus Liberte Atom Stent yielded a two-year target lesion revascularization rate that was 60% less than the Taxus Express Atom Stent. I am pleased to be able to offer this option to my patients, he added.